SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SK Biopharmaceuticals Submits FDA Application for Xcopri

SquawkNews Desk 2 updates Updated Nov 04, 2026, 12:59 AM UTC

Story updates

12:59:21 AM UTC
SquawkNews
BRIEF-Sk Biopharmaceuticals Co Submits FDA Application For Xcopri SK Biopharmaceuticals Co Ltd 32603
12:59:26 AM UTC
SquawkNews
SK Biopharmaceuticals Co Ltd KRX:326030

Related stories

Orcoda Announces Three-Year Contract With Linked Community Services M impact | EQUITY | Nov 04, 2026, 01:46 AM UTC Hang Seng Healthcare Index rises 3% M impact | EQUITY | Nov 04, 2026, 01:46 AM UTC Pan American Silver Raises Stake in Galleon Gold M impact | EQUITY | Nov 04, 2026, 01:45 AM UTC ChangXin Technology rebounds 3.4% as chair proposes larger buyback ChangXin Technology shares rebounded 3.4% in early Wednesday trading. The company said its chairman proposed increasing the stock repurchase amount. M impact | EQUITY | Nov 04, 2026, 01:45 AM UTC E-mini Nasdaq futures fall 1.8%; S&P 500 futures down 0.8% M impact | EQUITY | Nov 04, 2026, 01:45 AM UTC Pan American Silver Acquires 6.25 Million Galleon Gold Shares Pan American Silver acquired 6,250,000 Galleon Gold common shares for C$1.12 per share in a non-brokered private placement. M impact | EQUITY | Nov 04, 2026, 01:45 AM UTC